⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9280255 | 0.78 | — | — | |
| SCHEMBL9906573 | 0.75 | — | — | |
| SCHEMBL11574457 | 0.64 | — | — | |
| SCHEMBL841951 | 0.63 | — | — | |
| SCHEMBL12629902 | 0.63 | — | — | |
| SCHEMBL16908369 | 0.62 | — | — | |
| SCHEMBL16908397 | 0.60 | — | — | |
| SCHEMBL8180658 | 0.60 | TRPA1 (0.48) | — | |
| SCHEMBL9773480 | 0.60 | — | — | |
| SCHEMBL1679686 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240241018-A1 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-07-18 | — | — | US | disclosed |
| US-20240229107-A1 | MULTI-PART OLIGONUCLEOTIDE PROBES AND METHODS OF USE THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-07-11 | — | — | US | disclosed |
| US-20240229118-A1 | CONTROLLED ROLLING CIRCLE AMPLIFICATION | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-07-11 | — | — | US | disclosed |
| US-11913071-B2 | Methods and compositions for sequencing complementary polynucleotides | Singular Genomics Systems, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2024031061-A1 | METHODS FOR IMPROVING STRAND INVASION EFFICIENCY | Singular Genomics Systems, Inc. (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20240026428-A1 | METHODS FOR IN SITU TRANSCRIPTOMICS AND PROTEOMICS | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-01-25 | — | — | US | disclosed |
| US-20230374572-A1 | MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-11-23 | — | — | US | disclosed |
| US-20230366013-A1 | SPATIAL SEQUENCING | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-11-16 | — | — | US | disclosed |
| US-20230357843-A1 | NUCLEIC ACID CIRCULARIZATION AND AMPLIFICATION ON A SURFACE | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-11-09 | — | — | US | disclosed |
| US-20230357828-A1 | SPATIAL SEQUENCING OF MODIFIED SEQUENCES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-11-09 | — | — | US | disclosed |
| WO-2021231263-A2 | NUCLEIC ACID AMPLIFICATION METHODS | Singular Genomics Systems, Inc. (US) | 2021-11-18 | — | — | WO | disclosed |
| WO-2021226327-A1 | NUCLEOTIDE CLEAVABLE LINKERS WITH RIGID SPACERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021138094-A1 | POLYNUCLEOTIDE BARCODES FOR LONG READ SEQUENCING | Singular Genomics Systems, Inc. (US) | 2021-07-08 | — | — | WO | disclosed |
| WO-2021133685-A1 | METHODS FOR LONG READ SEQUENCING | Singular Genomics Systems, Inc. (US) | 2021-07-01 | — | — | WO | disclosed |
| US-10822653-B1 | Nucleotide cleavable linkers and uses thereof | Singular Genomics Systems, Inc. (US) | 2020-11-03 | — | — | US | disclosed |
| US-20200340051-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2020-10-29 | — | — | US | disclosed |
| WO-2020146397-A1 | NUCLEOTIDE CLEAVABLE LINKERS AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2020-07-16 | — | — | WO | disclosed |
| EP-3541792-A1 | TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | Amgen Inc. (US) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018097944-A1 | TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2018-05-31 | — | — | WO | disclosed |
| US-9353092-B2 | Synthesis and use of croconaine compounds | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2016-05-31 | — | — | US | disclosed |